Cargando…

Escalation of radiotherapy dose in large locally advanced drug-resistant gastrointestinal stromal tumors by multi-shell simultaneous integrated boost intensity-modulated technique: a feasibility study

BACKGROUND: Resistance to conventional dose schemes and radiotoxicity of healthy tissue is a clinical challenge in the radiation therapy of large locally advanced drug-resistant gastrointestinal stromal tumor (LADR-GIST). This study aimed to assess the feasibility of using multi-shell Simultaneous I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Haixia, Li, Ying, Huang, Wei, Lu, Wenli, Yi, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795666/ https://www.ncbi.nlm.nih.gov/pubmed/36578008 http://dx.doi.org/10.1186/s13014-022-02179-z

Ejemplares similares

Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Drug-Resistant Gastrointestinal Stromal Tumors: A Feasibility Study
por: Li, Longhao, et al.
Publicado: (2020)

Partially ablative radiotherapy (PAR) for large mass tumors using simultaneous integrated boost: A dose‐escalation feasibility study
por: Cilla, Savino, et al.
Publicado: (2018)

Dose-escalated Radiotherapy with Simultaneous Integrated Boost for Bone Metastases in Selected Patients with Assumed Favourable Prognosis
por: Potkrajcic, Vlatko, et al.
Publicado: (2022)

Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost
por: Embring, Anna, et al.
Publicado: (2023)

Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gastrointestinal organs remain critical
por: Stefanowicz, Sarah, et al.
Publicado: (2020)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost
por: Pinkawa, Michael, et al.
Publicado: (2012)

Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
por: Cihoric, Nikola, et al.
Publicado: (2015)

Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma
por: Fareed, Muhammad M, et al.
Publicado: (2013)

Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques
por: Aly, Moamen M.O.M., et al.
Publicado: (2015)

An imaging evaluation of the simultaneously integrated boost breast radiotherapy technique
por: Turley, Jessica, et al.
Publicado: (2015)

Clinical Implication of Simultaneous Intensity-modulated Radiotherapy Boost to Tumor Bed for Cervical Cancer with Full-thickness Stromal Invasion
por: Zhang, Zongkai, et al.
Publicado: (2022)

Feasibility and Outcomes of Hypofractionated Simultaneous Integrated Boost-Intensity Modulated Radiotherapy for Malignant Gliomas: A Preliminary Report
por: Cha, Jihye, et al.
Publicado: (2014)

Preliminary analysis of the sequential simultaneous integrated boost technique for intensity-modulated radiotherapy for head and neck cancers
por: Miyazaki, Masayoshi, et al.
Publicado: (2016)

Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapy
por: Nguyen, Dan, et al.
Publicado: (2014)

Efficacy and feasibility of proton beam radiotherapy using the simultaneous integrated boost technique for locally advanced pancreatic cancer
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
por: Yadav, Budhi Singh, et al.
Publicado: (2022)

Dose-Escalated Intensity-Modulated Radiotherapy for the Management of Locally Advanced Cervical Cancer
por: Shewalkar, Balaji, et al.
Publicado: (2022)

Adaptive dose escalated radiotherapy in oropharyngeal cancers: a treatment planning feasibility study
por: Grocutt, Laura, et al.
Publicado: (2022)

Adjuvant whole breast radiotherapy with simultaneous integrated boost to tumor bed with intensity modulated radiotherapy technique in elderly breast cancer patients
por: Chen, Kuan-Wen, et al.
Publicado: (2020)

Simultaneous integrated boost with intensity modulated radiation therapy in brain oligometastases: A feasible technique for developing countries
por: Tiwari, Vivek, et al.
Publicado: (2015)

Intensity-modulated radiotherapy with simultaneous integrated boost for locoregionally advanced nasopharyngeal carcinoma
por: Yi, Junlin, et al.
Publicado: (2014)

Reduction and Escalation in the Dose of Sunitinib Were Adequately Effective against Gastrointestinal Stromal Tumor of the Small Intestine
por: Ogata, Misato, et al.
Publicado: (2019)

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
por: Thureau, Sébastien, et al.
Publicado: (2018)

Dosimetric and Radiobiological Comparison of Five Techniques for Postmastectomy Radiotherapy with Simultaneous Integrated Boost
por: Tang, Du, et al.
Publicado: (2020)

A Dosimetric Comparison of Dose Escalation with Simultaneous Integrated Boost for Locally Advanced Non-Small-Cell Lung Cancer
por: Yang, Wenjuan, et al.
Publicado: (2017)

Dose-escalation by hypofractionated simultaneous integrated boost IMRT in unresectable stage III non-small-cell lung cancer
por: Zhang, Qin, et al.
Publicado: (2022)

Dose‐escalated simultaneously integrated boost radiation protocol fails to result in a survival advantage for sinonasal tumors in dogs
por: Meier, Valeria, et al.
Publicado: (2022)

Simultaneous Integrated Boost for Dose Escalation in Node-Positive Cervical Cancer: 5-Year Experience in a Single Institution
por: Cheung, Elki Sze-Nga, et al.
Publicado: (2023)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer
por: Hepel, Jaroslaw T., et al.
Publicado: (2012)

Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer
por: Huang, Bao-Tian, et al.
Publicado: (2017)

Radiotherapy for Gastrointestinal Stromal Tumors
por: Ozkan, Emine Elif
Publicado: (2018)

Dosimetric feasibility of moderately hypofractionated/dose escalated radiation therapy for localised prostate cancer with intensity-modulated proton beam therapy using simultaneous integrated boost (SIB-IMPT) and impact of hydrogel prostate-rectum spacer
por: Ahmad Khalil, Dalia, et al.
Publicado: (2022)

The Feasibility Study of a Hybrid Coplanar Arc Technique Versus Hybrid Intensity-modulated Radiotherapy in Treatment of Early-stage Left-sided Breast Cancer with Simultaneous-integrated Boost
por: Chen, Yuan-Gui, et al.
Publicado: (2017)

Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
por: Kornhuber, Christine, et al.
Publicado: (2023)

Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy
por: Chao, Hsing-Lung, et al.
Publicado: (2017)

The tumor core boost study: A feasibility study of radical dose escalation to the central part of large tumors with an integrated boost in the palliative treatment setting
por: Wittenstein, Olaf, et al.
Publicado: (2022)

Outcome of dose-escalated intensity-modulated radiotherapy for limited disease small cell lung cancer
por: Yang, Eunyeong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_inthdg4vo5mq1bvp749q9aad9v